Galmed Pharmaceuticals
GLMD
GLMD
21 hedge funds and large institutions have $19.5M invested in Galmed Pharmaceuticals in 2020 Q4 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 5 reducing their positions, and 7 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less ownership
Funds ownership: →
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
43% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 7
Holders
21
Holding in Top 10
1
Calls
–
Puts
–
Top Buyers
| 1 | +$265K | |
| 2 | +$254K | |
| 3 | +$100K | |
| 4 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
+$33K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$32K |
Top Sellers
| 1 | -$480K | |
| 2 | -$453K | |
| 3 | -$443K | |
| 4 |
RJA
Raymond James & Associates
St Petersburg,
Florida
|
-$275K |
| 5 |
EMG
ETF Managers Group
Summit,
New Jersey
|
-$254K |